Hepatitis C and pregnancy;Hépatite C et grossesse

Revue de Medecine Interne

Volumn 23, Issue 3, 2002, Pages 283-291

  Alric, L ^a   Costedoat, N ^b   Piette, J C ^b   Duffaut, M ^a   Cacoub, P ^b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Breast feeding; HCV; Mother to infant transmission; Pregnancy; Viral hepatitis C

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CHILDBIRTH; FEMALE; FETUS; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INTRAUTERINE INFECTION; PERINATAL INFECTION; PREGNANCY; PREVALENCE; RISK ASSESSMENT; VERTICAL TRANSMISSION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0036195631     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00553-7     Document Type: Article

References (70)

1. Recherche des anticorps contre le virus de l'hépatite C chez les femmes enceintes d'origine étrangère vivant en France
2. Prévalence des anticorps dirigés contre le virus de l'hépatite C (test ELISA 2 et RIBA 2) dans une population de femmes enceintes
3. Prevalence of hepatitis C virus infection in asymptomatic anti-HIV 1 negative pregnant women and their children
4. Antibodies to hepatitis virus in French blood donors
5. Seroprevalence and risks factor for hepatitis C virus antibody in pregnant women
6. Epidemic predictors of hepatitis C virus infection in pregnant women
7. Consensus statement EASL international consensus conference on hepatitis C
8. Interactions entre l'hépatite virale C et la grossesse
9. Studies on transmission of hepatitis C virus from mother to child in perinatal period
10. Hepatits C virus infection in gregnancy
11. Effect of pregnancy on chronic hepatitis C a case control study
12. Decrease in serum ALT in serum HCV RNA during pregnancy in women with chronic hepatitis C
13. Influence of pregnancy on aminotransferase levels and viremia in women with chronic hepatitis C
14. Progesterone and oestradiol suppress human mononuclear cell cytotoxicity
15. Changes in natural killer cell activity in normal pregnant and post-partum women; increase in the first and postpartum period and decrease in late pregnancy
16. Prevalence and clinical course of chronic Hepatitis C virus infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women
17. Failure to detect vertical transmission of hepatitis C virus
18. Mother-to-infant transmission of hepatitis C virus
19. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction
20. The incidence of vertical transmission of hepatits C virus
21. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: A prospective study with hepatitis C virus RNA testing
22. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus
23. Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immonodeficiency virus coinfection
24. Transmission of hepatitis C virus from mothers to infants
25. Effect of hepatitis C genotype on mother-to-infant transmission of virus
26. Higth efficiency of vertical transmission of hepatitis C virus among babies born to human immunodeficiency virus negative women
27. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population
28. Mother-to-infant transmission of hepatitis C virus
29. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern
30. Vertical transmission of hepatitis C virus infection
31. Vertical transmission of hepatitis C virus: An épidémiological study on 2890 pregnant women in Italy
32. Natural history of perinatal hepatitis C virus infection
33. Vertical transmission of hepatitis C virus in lowrisk pregnant women
34. Mother to child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region
35. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug using mothers: Rate of infection and assessment of risk factors for transmission
36. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1
37. Vertical transmission of hepatitis C virus, evidence of in utero infection
38. Vertical transmission of hepatitis C virus infection usefulness of viremia detection in HIV seronegative hepatitis C virus seropositive mothers
39. Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection
40. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers
41. Mother to child transmission of hepatitis C virus: Prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1
42. Hepatitis C virus infection in the mothers and infants: Cohort study
43. Vertical transmission of hepatits C virus
44. Detection of hepatitis C virus antibodies and specific hepatitis C virus ribonucleic acid sequences in cord bloods from a heterogeneous prenatal population
45. Transmission of hepatits C virus from mothers to infants: Its frequency and risk factors revisited
46. Transmission verticale du virus de l'hépatite C (VHC)
47. Infrequent vertical transmission of hepatitis C virus
48. Transmission materno-infantile du virus de l'hépatite C
49. Role of mother-child immunogenetic profiles in HCV vertical transmission
50. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection
51. Mondelli MU
52. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission
53. Absence of infection in breast-fed infants born of hepatitis C virus-infected mothers
54. Role of breast feeding in transmission of hepatitis C virus to infants of HCV-infected mothers
55. Hepatitis C virus in saliva and breast milk of hepatitis C carrier mother
56. Sexual and perinatal transmission of hepatitis C
57. Conférence de concensus: Hépatite C dépistage et traitement
58. Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: A prospective study
59. Hepatitis C virus in body fluids after liver transplantation
60. Detection of HCV-RNA in saliva of patients with chronic hepatitis C
61. Detection of HCV RNA in saliva, urine, seminal fluid ans ascites
62. Meta-analysis of interferon randomised trials in the treatment of viral hepatitis C: Effect of dose and duration
63. Case report of interferon alpha therapy for multiple myeloma during pregnancy
64. Randomized trial of interferon alpha-2-b plus ribavirine for 48 weeks or 24 weeks versus interferon alpha-2-b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
65. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
66. Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction
67. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C
68. Assistance médicale à la procréation et virus des hépatites: les problèmes posés aux hépatologues
69. Transmissions of hepatitis C virus during the ancillary procedures for assisted conception
70. Chronic hepatitis C in children: The pathological and clinical spectrum